List view / Grid view
19 April 2016 | By Victoria White, Digital Content Producer
Results of a new study could help researchers develop more effective combination therapies and breathe new life into forgotten pancreatic cancer drugs...
19 April 2016 | By Victoria White, Digital Content Producer
New preclinical data show the combination of lenvatinib and everolimus yield greater antitumour activity than either agent alone in kidney cancer...
19 April 2016 | By Victoria White, Digital Content Producer
Enterome has signed a license agreement with Vertex to research, develop and commercialise novel small molecule FimH antagonists...
18 April 2016 | By Victoria White, Digital Content Producer
A biodegradable nanoparticle, developed by researchers at Northwestern Medicine, offers an innovative way to halt asthma...
18 April 2016 | By Victoria White, Digital Content Producer
IPI-549 is an orally administered immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma)...
18 April 2016 | By Victoria White, Digital Content Producer
SEL24 is a dual inhibitor of PIM and FLT3 kinases. It is the first molecule with this mechanism of action to progress to such stage of development...
18 April 2016 | By Victoria White, Digital Content Producer
Heptares and Kymab are to colllaborate to discover, develop and commercialise novel antibody therapeutics targeting a number of GPCRs...
15 April 2016 | By Victoria White, Digital Content Producer
An analysis comparing the differences between over 40 strains of Zika virus identified significant changes in both amino acid and nucleotide sequences...
15 April 2016 | By Victoria White, Digital Content Producer
Researchers from MIT and MGH have developed a small, implantable device that delivers chemotherapy drugs directly to pancreatic tumours...
15 April 2016 | By Victoria White, Digital Content Producer
A study suggests that stimulating heat production in brown adipose tissue can improve weight-management and glucose tolerance...
14 April 2016 | By SMi Group
SMi’s 16th annual Pain Therapeutics conference returns to London this May and is thrilled to have Dr Geert Jan Groeneveld, Research Director from the Centre for Human Drug Research, as one of the featured speakers for 2016...
14 April 2016 | By Victoria White, Digital Content Producer
Cancer cells use a mutant gene to coerce neighbouring healthy tissue into helping with the disease’s growth and spread, a major new study reports...
14 April 2016 | By Victoria White, Digital Content Producer
Apollo Therapeutics, the investment fund focused on driving therapeutic innovation through university collaboration, has appointed Dr Richard Butt as CEO...
14 April 2016 | By Victoria White, Digital Content Producer
The US Centres for Disease Control and Prevention (CDC) has concluded that Zika virus is a cause of microcephaly and other severe foetal brain defects...
13 April 2016 | By Victoria White, Digital Content Producer
Mathematicians and physicians at the University of Bonn have developed a new model for cancer immunotherapy using mathematics...
